《中国肺癌杂志》入选中国科技核心期刊(中国科技论文统计源期刊).pdfVIP

32

··中国肺癌杂志2025年月第28卷第期ChinJLungCancer,January2025,Vol.28,No.

lungcancer.AnticancerDrugs,2022,33(9):826-839.doi:0.097/30LiuL,HeJ,SunG,etal.TheN6‐methyladenosinemodificationenhances

CAD.000000000000328ferroptosisresistancethroughinhibitingSLC7AmRNAdeadenylation

27WangL,LiS,LuoH,etal.PCSK9promotestheprogressionandinhepatoblastoma.ClinTranslMed,2022,2(5):e778.doi:0.002/

metastasisofcoloncancercellsthroughregulationofEMTandctm2.778

PI3K/AKTsignalingintumorcellsandphenotypicpolarizationof3ZhangR,WuD,WangY,etal.LncRNAMIR3HGisactivatedby

macrophages.JExpClinCancerRes,2022,4():303.doi:0.86/STATandfacilitatesglioblastomacellgrowthviaWnt/β-catenin

s3046-022-02477-0signalingpathway.NeurosciRes,202:S068-002(2)00092-4.doi:

28AlannanM,FatrouniH,TrézéguetV,etal.TargetingPCSK9inliver0.06/j.neures.202.04.008

cancercellstriggersmetabolicexhaustionandcelldeathbyferroptosis.

Cells,2022,2():62.doi:0.3390/cells2000622024-2-03

（收稿日期：）

29ZhangY,DongP,LiuN,etal.TRIM6reducesferroptosisand（本文编辑：丁燕）

chemosensitivitybytargetingSLCA5inlungcancer.OxidMedCell

Longev,2023,2023:980800.doi:0.55/2023/980800

Citethisarticleas:ZhangZR,ZhaoWH,HuZX,etal.Constructionandvalidationofapro